Filing Flows › GoodRx Holdings (GDRX) › Next earnings date
GoodRx Holdings (GDRX) earnings on Nov 9, 2026: what to expect
GoodRx Holdings (GDRX) is expected to report earnings on Nov 9, 2026 (estimated), tomorrow, for the quarter ending Sep 30, 2026. Analysts expect EPS of $0.08 ($0.07 to $0.10, 11 estimates) on revenue of $202M, against $0.08 and $196M a year ago. It beat the EPS estimate in 25% of the quarters on record; Filing Flows' model gives it a 58% chance of beating next time.
What to watch
Last quarter (Q2 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:
Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS $0.04 on revenue of $195M, against the analysts' $0.08.
The last report
GoodRx Holdings reported revenue of $200M for the second quarter 2026 (-1% Y/Y), net earnings $8.5M: Prescription transactions revenue $106M, Pharma Direct revenue $61.6M, Subscription revenue $28.5M, Other revenue $3.9M. How it makes money → · Every quarter →
GoodRx Holdings' latest quarter
GoodRx Holdings, Q2 2026: revenue $200M (-1% year over year), operating margin 11.8%, net earnings $8.5M, operating cash flow $80.8M. The chart follows the revenue to costs, profit and cash.
Questions
When does GDRX report earnings?
GoodRx Holdings is expected to report on Nov 9, 2026 (estimated).
What are analysts expecting from GoodRx Holdings?
EPS of $0.08 and revenue of $202M for the quarter.
Does GoodRx Holdings usually beat earnings?
It beat the consensus EPS estimate in 25% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.